Structural characterization and in vivo immunosuppressive activity of neuroblastoma GD2

Glycoconjugate Journal

Volumn 13, Issue 3, 1996, Pages 385-389

  Li, Ruixiang ^a   Gage, Douglas ^b   Mckallip, Robert ^a   Ladisch, Stephan ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Michigan State University ^*  (United States)

Author keywords

Ganglioside GD2; Immunosuppression in vivo; Mass spectrometry

Indexed keywords

MURINAE;

GANGLIOSIDE;

ARTICLE; CARCINOGENESIS; CELLULAR IMMUNITY; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; NEUROBLASTOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CARBOHYDRATE SEQUENCE; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; GANGLIOSIDES; HUMANS; IMMUNITY, CELLULAR; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MASS SPECTROMETRY; MICE; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; TUMOR CELLS, CULTURED;

EID: 0029938789     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00731471     Document Type: Article

References (33)

1. Travis J (1992) Science 258: 1732-33.
2. Ladisch S, Gillard B, Wong C, Ulsh L (1983) Cancer Res 43: 3808-13.
3. Ladisch S, Kitada S, Hays E (1987) J Clin Invest 79: 1879-82.
4. Valentino L, Moss T, Olson E, Wang H-j, Elashoff R, Ladisch S (1990) Blood 75: 1564-67.
5. Floutsis G, Ulsh L, Ladisch S (1988) Int J Cancer 43: 6-9.
6. Ladisch S, Li R, Olson E (1994) Proc Natl Acad Sci USA 91: 1974-78.
7. Gonwa TA, Westrick MA, Macher BA (1984) Cancer Res 44: 3467-70.
8. Hoon D, Irie R, AC (1988) Cellular Immunol III: 410-19.
9. Lengle EE, Krishnaraj R, Kemp RG (1979) Cancer Res 39: 817-22.
10. Ryan J, Shinitzky M (1979) Eur J Immunol 9: 171-75.
11. Whisler R, Yates A (1980) J Immunol 125: 2106-11.
12. Ladisch S, Becker H, Ulsh L (1992) Biochim Biophys Acta 1125: 180-88.
13. Grayson G, Ladisch S (1992) Cellular Immunol 139: 18-29.
14. Massa PT (1993) J Exp Med 178: 1357-63.
15. Repke H, Barber E, Ulbricht S, Buchner K, Hucho F, Kopp R, Scholz H (1992) J Immunol 149: 2585-91.
16. Li R, Ladisch S (1991) Biochim Biophys Acta 1083: 57-64.
17. Li R, Ladisch S (1992) J Neurochem 59: 2297-303.
18. Ladisch R, Gillard BA (1985) Anal Biochem 146: 220-31.
19. Ledeen R, Yu R (1982) Methods Enzymol 83: 139-91.
20. Gazzotti G, Sonnino S, Ghidoni R (1985) J Chromatogr 348: 371-78.
21. Ladisch S, Sweeley C, Becker H, Gage D (1989) J Biol Chem 264: 12097-105.
22. Kroczek RA, Black CDV, Barbet J, Edison LJ, Shevach EM (1987) Transplantation 44: 547-53.
23. Li R, Villacreses N, Ladisch S (1995) Cancer Res 55: 211-14.
24. Morris RE, Wu J, Shorthouse R (1990) Transplant Proc 22: 1638-41.
25. Hachida M, Uwabe K, Nonoyama M, Imamaki M, Nemoto S, Hoshi H, Katsumata T, Endo M, Koyanagi H (1993) Transplantation 56: 479-82.
26. Ladisch S, Wu Z-L (1985) Prog Clin Biol Res 175: 277-84.
27. Schulz G, Cheresh D, Varki N, Yu A, Staffileno L, Reisfeld R (1984) Cancer Res 44: 5914-20.
28. Saito M, Yu RK, Cheung NK (1985) Biochem Biophys Res Commun 127: 1-7.
29. Gross N, Beck D, Portoukalian J, Favre S, Carrel S (1989) Int J Cancer 43: 665-71.
30. Wu Z-L, Schwartz E, Seeger R, Ladisch S (1986) Cancer Res 46: 440-43.
31. Ladisch S, Wu Z-L, Feig S, Ulsh L, Schwartz E, Floutsis G, Wiley F, Lenarsky C, Seeger R (1987) Int J Cancer 39: 73-76.
32. Ladisch S, Wu Z-L (1985) Lancet i: 136-38.
33. Valentino L, Ladisch S (1992) Cancer Res 52: 810-14.